Merck & Company Inc (MRK)
Merck & Company Inc (MRK) carries a ŷRobot AI score of 54 out of 100. The model's fair value estimate is $144.59, 2.1% below the last close of $147.76. The chart signal reads Hold.
| Metric | MRK |
|---|---|
| AI score | 54 / 100 |
| Chart signal | Hold |
| Fair value estimate | $144.59 |
| Upside to fair value | -2.1% |
| Previous close | $147.76 |
| P/E | 151.03 |
| Price / sales | 5.48 |
| Market cap | $362.27B |
| EPS | 0.99 |
| Revenue growth | 3.4% |
| 1-year price change | 1.3% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, UnitedHealth Group Incorporated, Novartis AG ADR, AstraZeneca PLC.
Questions about MRK
Is MRK overvalued or undervalued right now?
As of Nov 3, 2026, ŷRobot's fair-value model estimates Merck & Company Inc (MRK) at $144.59 against a last close of $147.76, implying 2.1% downside to the model's estimate.
Is MRK's chart signal bullish or bearish?
The chart-signal model classifies MRK as Neutral as of Nov 13, 2026, with a signal score of 0.00 on a -1 to 1 scale.
What is MRK's ŷRobot AI score?
MRK scores 54 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Nov 13, 2026.
Is MRK stock expensive on P/E and P/S?
MRK trades at 151.0 times earnings and 5.5 times sales as of Nov 13, 2026.
What does MRK's seasonal forecast show?
ŷRobot's seasonal forecast curve for MRK reads +3.6% at 30 days, +4.5% at 90 days, and +1.3% at one year as of Nov 13, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is MRK growing?
Merck & Company Inc's revenue growth is +3.4% and free-cash-flow growth is +32.1% on the latest reported figures.
MRK chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.